RAD Price sensitive 1 Oct 2025, 9:18 AM

Radiopharm received approval for RAD 202 trial acceleration

Radiopharm Theranostics Ltd

No summary is available for this announcement — sign in to read the PDF in full.

Sign in for more about this company, including guidance changes and other insights.
Sign in